JPMorgan Chase & Co’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $47.9K | Sell |
|
|||||
|
2024
Q1 | $236K | Buy |
|
|||||
|
2023
Q4 | $763 | Sell |
|
|||||
|
2023
Q3 | $13.5K | Sell |
|
|||||
|
2023
Q2 | $5.27M | Sell |
|
|||||
|
2023
Q1 | $5.76M | Buy |
|
|||||
|
2022
Q4 | $11.1M | Sell |
|
|||||
|
2022
Q3 | $25.5M | Sell |
|
|||||
|
2022
Q2 | $10.5M | Buy |
|
|||||
|
2022
Q1 | $15.9M | Sell |
|
|||||
|
2021
Q4 | $21.9M | Sell |
|
|||||
|
2021
Q3 | $30.1M | Buy |
|
|||||
|
2021
Q2 | $41.2M | Buy |
|
|||||
|
2021
Q1 | $44M | Buy |
|
|||||
|
2020
Q4 | $30M | Buy |
|
|||||
|
2020
Q3 | $19.8M | Sell |
|
|||||
|
2020
Q2 | $49.6M | Buy |
|
|||||
|
2020
Q1 | $18.7M | Buy |
|
|||||
|
2019
Q4 | $44.1M | Buy |
|
|||||
|
2019
Q3 | $28.4M | Sell |
|
|||||
|
2019
Q2 | $44.4M | Buy |
|
|||||
|
2019
Q1 | $18.6M | Buy |
|
|||||
|
2018
Q4 | $19.7M | Buy |
|
|||||
|
2018
Q3 | $27.8M | Buy |
|
|||||
|
2018
Q2 | $19.8M | Buy |
|
|||||
|
2018
Q1 | $8.21M | Buy |
|
|||||
|
2017
Q4 | $311K | Buy |
|